Why Proteona

The ESCAPE Technology

The ESCAPETM Technology

The enhanced single cell analysis with protein expression (ESCAPE) platform represents a suite of technologies developed by Proteona using DNA barcoded antibodies. It empowers us to obtain both proteomic and genomic information from the same single cells.

Maximize information

Maximize Information

With the power of the ESCAPE platform, you can now phenotype cells based on protein panels measuring >50 protein markers, while simultaneously measuring all potential mRNAs in each cell. ESCAPE provides the greatest insights possible into clinically important samples.

Global presence

Global Presence

Based in Singapore with additional operations in the US and Germany, Proteona has been assisting clinical laboratories around the world with their ESCAPE kit, sample-to-answer services, and bioinformatics support.

MANAGEMENT AND SCIENTIFIC FOUNDERS

Andreas Schmidt

Andreas Schmidt, PhD

Chief Executive Officer

Andreas is a serial entrepreneur and a successful biotech CEO in both Asia and Europe. He previously built up the venture capital backed proteomics company AYOXXA with a 45 people team in Singapore, Cologne and Boston raising more than 40 Million USD. He currently serves as a board member, advisor and mentor for several biotech companies, including Venneos and Aescuvest.

Jonathan Scolnick

Jonathan Scolnick, PhD

Scientific Co-founder

Jonathan has brought multiple research and diagnostic technologies from conception to market. As a scientist at Natera, he developed multiple genetic diagnostic tests and implemented them into the clinical service lab. He has also subsequently led four products from concept to market at NuGen Technologies (products created under the Ovation™ line) and his own company, Alaneo Genetics.

Shawn Hoon

Shawn Hoon, PhD

Scientific Co-founder

Shawn has been involved with many large-scale genome projects ranging from the sequencing of the Fugu genome to chemical genomic profiling. He has published widely in the area of bioinformatics and next-generation sequencing and has worked closely with Dr. Sydney Brenner to establish the Molecular Engineering Laboratory and managing a multidisciplinary team of 20 scientists.

ADVISORY BOARD

Charles Goldstein

Charles Goldstein, PhD

Dr. Goldstein is the former SVP/CTO Greater Asia of Beckton Dickson, and serves as Board member for innovative start-up companies. Dr. Goldstein’s leadership resulted in many new commercialised medical devices and diagnostic products whose annual sales total in the billions. He has championed new innovation sources that include start-up incubators in the US and Singapore.

Gene Yeo

Gene Yeo, PhD, MBA

Dr. Yeo is a Professor of Cellular and Molecular Medicine at the University of California,San Diego (UCSD). He has authored more than 160 peer-reviewed publications and books. Dr. Yeo is a co-founder of biotech companies which includes Locana, Eclipse Bioinnovations, Enzerna and Proteona. He serves or had served on the scientific advisory boards of various start-ups.

CAREERS

Career Opportunities

Proteona is the leader in single cell analysis and to revolutionize immuno-oncology and immune profiling. We are constantly challenging new boundaries of technologies. You can join us to help make a difference in science, diagnosis, and medicine.


We are growing, grow with us.
Jobs

Proteona Pte. Ltd. is seeking a Computational Biology Scientist immediately.

Send us your resume and we will get in touch if you are shortlisted.

Apply now
CONTACT US

Proteona Pte. Ltd.
2 Jurong East Street 21 #04-20
Singapore 609601

Proteona GmbH
Cologne, Germany

info@proteona.com

World map